triazolam has been researched along with Auricular Fibrillation in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our data indicate that oral triazolam is beneficial in decreasing pain and anxiety associated with self-activated atrial defibrillation." | 9.12 | Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. ( Bigos, KL; Corey, SE; Fabian, TJ; Kroboth, PD; Pollock, BG; Schwartzman, DS; Ujhelyi, MR, 2006) |
| " Our data indicate that oral triazolam is beneficial in decreasing pain and anxiety associated with self-activated atrial defibrillation." | 5.12 | Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. ( Bigos, KL; Corey, SE; Fabian, TJ; Kroboth, PD; Pollock, BG; Schwartzman, DS; Ujhelyi, MR, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabian, TJ | 1 |
| Schwartzman, DS | 1 |
| Ujhelyi, MR | 1 |
| Corey, SE | 1 |
| Bigos, KL | 1 |
| Pollock, BG | 1 |
| Kroboth, PD | 1 |
| Mitchell, AR | 1 |
1 trial available for triazolam and Auricular Fibrillation
| Article | Year |
|---|---|
Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.
Topics: Adjuvants, Anesthesia; Administration, Oral; Adult; Aged; Anxiety; Atrial Fibrillation; Conscious Se | 2006 |
1 other study available for triazolam and Auricular Fibrillation
| Article | Year |
|---|---|
A placebo-controlled, crossover comparison of oral triazolam prior to sham patient-activated shock delivery during sinus rhythm in a group of patients with recurrent atrial fibrillation.
Topics: Atrial Fibrillation; Controlled Clinical Trials as Topic; Cross-Over Studies; Electric Countershock; | 2006 |